Abstract

ObjectivesTo evaluate the ability of post-chemo-radiotherapy (CRT) diffusion-weighted-MRI apparent diffusion coefficient (ADCmean) and 18F-FDG PET maximum standardized uptake value (SUVmax) to predict disease-free survival (DFS) in head and neck squamous cell carcinoma (HNSCC), and to determine whether this ability is influenced by human papillomavirus oropharyngeal cancer (HPV-OPC) status.MethodsThis prospective cohort observational study included 65 participants (53 male, mean ± SD age 59.9 ± 7.9 years, 46 HPV-OPC) with stage III or IV HNSCC. Primary tumour and nodal ADCmean (pre-treatment, 6- and 12-weeks post-CRT) and SUVmax (12-weeks post-CRT) were measured. Variables were compared with 2-year DFS (independent t-test/Mann–Whitney test) and overall DFS (Cox regression), before and after accounting for HPV-OPC status. Variables were also compared between HPV-OPC and other HNSCC subgroups after stratifying for DFS.ResultsAbsolute post-CRT ADCmean values predicted 2-year DFS and overall DFS for all participants (p = 0.03/0.03, 6-week node; p = 0.02/0.03 12-week primary tumour) but not in the HPV-OPC subgroup. In participants with DFS, percentage interval changes in primary tumour ADCmean at 6- and 12-weeks were higher in HPV-OPC than other HNSCC (p = 0.01, 6 weeks; p = 0.005, 12 weeks). The 12-week post-CRT SUVmax did not predict DFS.ConclusionAbsolute post-CRT ADCmean values predicted DFS in HNSCC but not in the HPV-OPC subgroup. Amongst participants with DFS, post-CRT percentage interval changes in primary tumour ADCmean were significantly higher in HPV-OPC than in other HNSCC. Knowledge of HPV-OPC status is crucial to the clinical utilisation of post-CRT DWI-MRI for the prediction of outcomes.

Highlights

  • Head and neck squamous cell cancer (HNSCC) is the seventh commonest cancer (Ferlay et al 2010)

  • Concomitant chemo-radiotherapy (CRT) is the standard of care for the advanced disease at most head and neck tumour sites, with treatment failing at loco-regional sites in over 30% of stage III or IV tumours (Goodwin 2000)

  • A number of studies have evaluated post-treatment tumour A­ DCmean as a biomarker (Kim et al 2009; King et al 2010; Vandecaveye et al 2012; Schouten et al 2014; Marzi et al 2017; Brenet et al 2020) with increased absolute ­ADCmean, or a greater percentage interval increase in A­ DCmean from pre-treatment values, being associated with the disease control (King et al 2010; Vandecaveye et al 2012; Brenet et al 2020)

Read more

Summary

Introduction

Head and neck squamous cell cancer (HNSCC) is the seventh commonest cancer (Ferlay et al 2010). Quantitative post-treatment 18F-FDG PET-CT ­SUVmax (Moeller et al 2009; Chan et al 2012; Sherriff et al 2012; Castelli et al 2016; Kim et al 2016; Matoba et al 2017) has been shown to predict treatment failure and survival outcomes. Quantitative diffusion-weighted MRI (DW-MRI) may provide alternative post-CRT imaging variables for the prediction of treatment success. A number of studies have evaluated post-treatment tumour A­ DCmean as a biomarker (Kim et al 2009; King et al 2010; Vandecaveye et al 2012; Schouten et al 2014; Marzi et al 2017; Brenet et al 2020) with increased absolute ­ADCmean, or a greater percentage interval increase in A­ DCmean from pre-treatment values, being associated with the disease control (King et al 2010; Vandecaveye et al 2012; Brenet et al 2020). Since DWMRI probes a different biological process to 18F-FDG PET-CT, the two modalities may be complementary in stratifying the risk of residual or recurrent disease (Preda et al 2016)

Objectives
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.